BREATHE Registry – I Brazilian Registry of Heart Failure
Overview
The purpose of this study is to evaluate the demographic, clinical, prognostics characteristics of 1,200 patients admitted with clinical diagnosis of decompensate heart failure in a group of 60 hospitals representative in different regions.
Full Title of Study: “BREATHE Registry – I Brazilian Registry of Heart Failure”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: July 2019
Detailed Description
Background: Several local registries seek to show an isolated clinical characteristics of patients hospitalized with heart failure (HF) in hospitals and communities in Brazil. Overall, the analysis of these data suggests that there are important differences in etiology, the factors of decompensation, treatment and prognosis of HF patients in different regions. Objectives: To evaluate the demographic, clinical, prognostics characteristics of 1,200 patients admitted with clinical diagnosis of decompensate heart failure in a group of 60 hospitals representative in different regions. Other specific objectives include describing the in-hospital mortality after admission, to describe the content and the reason for re-admission, to assess adherence to evidence-based guidelines (recommended by guidelines), to measure indicators of quality of care and establish a national registry data to allow for comparison with international records of patients admitted with ADHF. Methods: Observational cross (record) with longitudinal follow-up where patients admitted to public and private hospitals primarily defined in IC will be studied.
Arms, Groups and Cohorts
- Heart Failure patients (Breathe I)
- Patients admitted with clinical diagnosis of decompensate heart failure, > 18 years old.
- Heart Failure patients (Breathe Extension)
- Patients admitted with clinical diagnosis of decompensate heart failure, > 18 years old.
Clinical Trial Outcome Measures
Primary Measures
- Total mortality
- Time Frame: follow up at 3, 6 and 12 months
Secondary Measures
- Proportion of patients receiving interventions with proven benefit shown by different indicators of quality of care.
- Time Frame: follow up at 3, 6 and 12 months
Participating in This Clinical Trial
Inclusion Criteria
- > 18 years old, – Boston Criteria > 7, – patients hospitalized > 24 hours. Exclusion Criteria:
- myocardial revascularization during last month, – heart failure due to sepsis, – acute coronary syndrome with ventricular dysfunction as reason for current hospitalization
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Hospital do Coracao
- Collaborator
- Brazilian Society of Cardiology
- Provider of Information About this Clinical Study
- Sponsor
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.